SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 66.95 |
| Enterprise Value ($M) | -44.06 |
| Book Value ($M) | 174.14 |
| Book Value / Share | 10.20 |
| Price / Book | 0.38 |
| NCAV ($M) | 154.66 |
| NCAV / Share | 9.05 |
| Price / NCAV | 0.43 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.84 |
| Return on Assets (ROA) | -0.51 |
| Return on Equity (ROE) | -0.58 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.38 |
| Current Ratio | 7.38 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 183.79 |
| Assets | 203.27 |
| Liabilities | 29.13 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 9.98 | 2.53 | |
| 13G | Solas Capital Management, LLC | |||
| 13G/A | Acorn Bioventures, L.p. | |||
| 13G/A | Vanguard Group Inc | 4.90 | 0.00 | |
| 13G/A | Westfield Capital Management Co Lp | 0.00 | -100.00 | |
| 13G/A | BlackRock, Inc. | 2.00 | -70.79 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 21,648 | 113,557 | 19.06 | |
| 36,354 | 150,574 | 24.14 | |
| 32,792 | 154,477 | 21.23 | |
| 35,173 | 200,817 | 17.51 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MNOV – MediciNova, Inc. | MRNS – Marinus Pharmaceuticals, Inc. |
| MRUS – Merus N.V. | NAII – Natural Alternatives International, Inc. |
| NAMS – NewAmsterdam Pharma Company N.V. |
Financial data and stock pages provided by
Fintel.io